The Marqués de Valdecilla Health Research Institute Foundation (IDIVAL) joined the European Human Resources Strategy for Researchers (HRS4R) in 2016 and obtained the “HR Excellence in Research” award in October 2018. This quality recognition is a key criterion for the renewal of accreditation as a Health Research Institute by the Carlos III Health Institute (ISCIII), […]
Nurses Nuria Sánchez and Paula Calvo, from the Clinical Trials Unit of the Marqués de Valdecilla University Hospital (HUMV/IDIVAL), have participated in an international study conducted within the framework of a clinical trial led by the Hematology Department. The results have just been published, providing the nursing staff’s perspective on a new drug delivery device […]
The donation is the result of the 15th edition of their solidarity event held in Los Corrales de Buelna, which brought together thousands of people in support of biomedical research in Cantabria. The Marqués de Valdecilla Research Institute (IDIVAL) received a €20,000 donation from the ‘Luchamos por la Vida’ Association, aimed at supporting a research […]
The Board of Trustees of the Marqués de Valdecilla Research Institute Foundation (IDIVAL) has approved its annual accounts for the 2024 financial year, confirming the institution’s financial stability and soundness. The meeting, held at the Government Pavilion of the University of Cantabria, also provided an opportunity to review a year marked by continuous growth in […]
The Marqués de Valdecilla Research Institute (IDIVAL) has allocated €465,000 this year to support the activity of the 30 research groups that make up the institute. This amount represents a significant increase compared to previous calls and is part of the Support program, which provides backing for the development of activities by IDIVAL’s research groups. […]
The Clinical and Translational Research Group in Digestive Diseases at the Marqués de Valdecilla Research Institute (IDIVAL) has just published an article in the Revista Española de Enfermedades Digestivas, reviewing and updating current knowledge on the calcitonin gene-related peptide (CGRP) and its role in the bidirectional communication between the central nervous system and the gastrointestinal […]
During the Regional Health Congress held in Comillas (Cantabria), two projects developed within the framework of the Joint Action PreventNCD were presented, focusing on health equity and approaches to tackling smoking. As part of Work Package 7 (WP7), professionals from the Marqués de Valdecilla University Hospital (HUMV) and the Marqués de Valdecilla Research Institute (IDIVAL) […]
The Marqués de Valdecilla Research Institute (IDIVAL) has joined this European initiative through its Medical Oncology and Hematologic Neoplasms and Hematopoietic Stem Cell Transplant teams, following their participation in the previous eCAN Joint Action. The new eCAN Plus Joint Action, officially launched this month in Brussels, aims to improve cancer prevention and care across Europe […]
On 24 June 2025, the Regional Minister of Health of the Government of Cantabria, César Pascual, presented the Award for International Trajectory in the Protection of the Right to Health to Professor Rafael Yuste Rojas, recognised as a ‘figure of international research relevance’. This award, promoted by the Regional Ministry of Health through the Health […]
Researcher María Muñoz San Martín, from the Marqués de Valdecilla Research Institute (IDIVAL), has been awarded the Cajal Award in the Neurology category in the first edition of these recognitions, promoted by Merck and the Autonomous University of Madrid (UAM) through its Chair of Innovation in Science and Health. The award ceremony took place on […]
